Manufacturer's investigation conclusion: the relevant sections of the device history record for (b)(6) were reviewed and showed no deviations from manufacturing or quality assurance specifications.The heartmate 3 left ventricular assist system (hm 3 lvas) instructions for use (ifu) is currently available.Section 1, ("introduction") lists potential adverse events that may be associated with the use of the hm3 lvas, including thrombus and arterial peripheral thromboembolism.Section 6, (¿patient care and management¿), lists potential late postimplant complications that may be associated with the use of the hm3 lvas, including thromboembolism, as well as provides information regarding anticoagulation, including the recommended international normalized ratio (inr) values.A direct correlation between the reported thrombus and heartmate 3 (hm3) left ventricular assist device (lvad) serial number (b)(6) could not be conclusively determined through this evaluation.The patient remains ongoing with heartmate 3 left ventricular assist system, serial number (b)(6), and no product is available for investigation.No further information was provided.The manufacturer is closing the file on this event.
|